Table 3 Fetal and maternal post partum outcomes in the IH and no IH groups
From: Clinical characteristics and sequelae of intrapartum hypertension – a retrospective cohort study
Total (n = 229) | ⩾2 elevated BP readings (n = 32) | < 2 elevated BP readings (n = 197) | p-value | Unadjusted odds ratio (95%CI) | |
|---|---|---|---|---|---|
Fetal outcomes | |||||
Male infant, n (%) | 118 | 18 (15.3%) | 100 (84.7%) | NS | |
1 minute APGAR score < 9, n (%) | 21 | 5 (23.8%) | 16 (76.2%) | NS | |
5 minute APGAR score < 9, n (%) | 9 | 3 (33.3%) | 6 (66.7%) | NS | |
Fetal weight (median ± IQR) | 3468 (± 746) | 3420 (± 904) | 3473 (± 695) | NS | |
Small-for-gestational age at delivery (<10th centile) | 13 | 3 (23.1%) | 10 (76.9%) | NS | |
Intrauterine growth restriction at delivery (<5th centile) | 5 | 1 (20%) | 4 (80%) | NS | |
Preterm delivery (< 37 weeks), n (%) | 10 | 1 (10%) | 9 (90%) | NS | |
Admission to special care nursery/neonatal intensive care unit, n (%) | 35 | 8 (22.9%) | 27 (77.1%) | NS | |
Fetal composite outcomea | 40 | 9 (22.5%) | 31 (77.5%) | NS | |
Maternal outcomes | |||||
Maternal ICU admission, n (%) | 0 | 0 (0%) | 0 (0%) | – | |
Length of stay following delivery (median ± IQR) | 2 (± 2) | 3 (± 1) | 2 (± 1) | < 0.01 | |
Length of stay > 3 days, n (%) | 17 | 4 (23.5%) | 13 (76.5%) | NS | |
Postpartum hypertension, n (%) | 19 | 6 (31.6%) | 13 (68.4%) | 0.02 | 3.27 (1.14–9.34) |
Required IV antihypertensive agents | 0 | 0 (0%) | 0 (0%) | – | |
Discharged with antihypertensive medications | 4 | 4 (100%) | 0 (0%) | < 0.01 | 1.14 (1.00–1.30) |
Readmission due to hypertension, n (%) | 3 | 0 (0%) | 3 (100%) | NS | |
Maternal composite outcomeb | 5 | 2 (40%) | 3 (60%) | NS | |